Dr. Eve Cunningham is group vice president and chief of virtual care and digital health at health system Providence and founder of MedPearl. And Providence is getting ready to spin off MedPearl.

Deployment of artificial intelligence for point-of-care clinical decision support is in its infancy. Despite media attention and proliferation of AI studies, translation to clinical practice is not ...

Like virtually every other industry, health care is increasingly prioritizing digital transformation. The sector is unique, however, in that its results are measured not only in business terms but ...

Evidence that clinical decision support systems (CDSS) reduce unwarranted variation in care and improve patient outcomes remains limited, particularly for acute, high-risk conditions where deviations ...

Amber Nigam is CEO and cofounder of basys.ai, a Harvard-based company streamlining prior authorization for health plans with generative AI. A few years ago, artificial intelligence (AI) promised to ...

Here we conducted a retrospective evaluation of an electronic medical record-embedded large language model clinical decision support system deployed across 16 primary care clinics in Kenya, between ...

Medical large language models (LLMs) are increasingly being used in clinical settings. For example, AI is helping doctors in ...

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study The IPSS-M provides important new ...

Kunal is a thought leader in Digital Journal’s Insight Forum (become a member). The intersection of Artificial Intelligence (AI) and analytics-based decision support systems has the potential to ...

A clinical decision support system (CDSS) for chronic kidney disease (CKD) does not improve physician behavior or patient outcomes over a control intervention, according to a study published online ...

The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...